Boston Partners lowered its stake in Olin Corporation (NYSE:OLN) by 33.4% during the second quarter, Holdings Channel reports. The fund owned 632,190 shares of the specialty chemicals company’s stock after selling 316,585 shares during the period. Boston Partners’ holdings in Olin Corporation were worth $19,143,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in OLN. BlackRock Inc. increased its position in Olin Corporation by 7,604.7% in the first quarter. BlackRock Inc. now owns 19,895,613 shares of the specialty chemicals company’s stock valued at $653,967,000 after buying an additional 19,637,387 shares during the last quarter. Vanguard Group Inc. increased its position in Olin Corporation by 6.5% in the first quarter. Vanguard Group Inc. now owns 14,410,405 shares of the specialty chemicals company’s stock valued at $473,671,000 after buying an additional 878,440 shares during the last quarter. Bank of New York Mellon Corp increased its position in Olin Corporation by 51.8% in the first quarter. Bank of New York Mellon Corp now owns 3,176,770 shares of the specialty chemicals company’s stock valued at $104,421,000 after buying an additional 1,083,395 shares during the last quarter. Macquarie Group Ltd. increased its position in Olin Corporation by 5.0% in the first quarter. Macquarie Group Ltd. now owns 3,051,997 shares of the specialty chemicals company’s stock valued at $100,319,000 after buying an additional 145,929 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in Olin Corporation by 4.0% in the first quarter. Ameriprise Financial Inc. now owns 2,146,387 shares of the specialty chemicals company’s stock valued at $70,552,000 after buying an additional 83,276 shares during the last quarter. 93.02% of the stock is owned by institutional investors.

Olin Corporation (NYSE:OLN) opened at 30.50 on Wednesday. Olin Corporation has a 52 week low of $18.24 and a 52 week high of $33.88. The firm’s 50 day moving average price is $30.41 and its 200-day moving average price is $30.80. The firm has a market cap of $5.07 billion, a PE ratio of 118.68 and a beta of 1.43.

Olin Corporation (NYSE:OLN) last issued its quarterly earnings data on Monday, July 31st. The specialty chemicals company reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.16 by $0.15. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.51 billion. Olin Corporation had a return on equity of 5.80% and a net margin of 0.72%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.24 earnings per share. On average, analysts forecast that Olin Corporation will post $1.14 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 11th. Investors of record on Thursday, August 10th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend is Tuesday, August 8th. Olin Corporation’s dividend payout ratio is presently 320.00%.

TRADEMARK VIOLATION NOTICE: “Boston Partners Sells 316,585 Shares of Olin Corporation (OLN)” was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.watchlistnews.com/boston-partners-sells-316585-shares-of-olin-corporation-oln/1493661.html.

Several equities research analysts have recently issued reports on the company. BidaskClub upgraded Olin Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, June 21st. Zacks Investment Research upgraded Olin Corporation from a “sell” rating to a “hold” rating in a report on Thursday, April 20th. Tudor Pickering assumed coverage on Olin Corporation in a report on Friday, May 12th. They set a “buy” rating and a $37.00 price objective on the stock. UBS AG restated a “neutral” rating and set a $30.00 price objective (down previously from $33.00) on shares of Olin Corporation in a report on Sunday, June 25th. Finally, Cowen and Company restated an “outperform” rating and set a $39.00 price objective (up previously from $37.00) on shares of Olin Corporation in a report on Thursday, June 22nd. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $32.75.

In other Olin Corporation news, EVP John L. Mcintosh sold 16,070 shares of the company’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $31.02, for a total transaction of $498,491.40. Following the completion of the sale, the executive vice president now directly owns 60,391 shares in the company, valued at $1,873,328.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP John L. Mcintosh sold 24,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $31.54, for a total transaction of $756,960.00. Following the sale, the executive vice president now owns 84,391 shares of the company’s stock, valued at $2,661,692.14. The disclosure for this sale can be found here. Corporate insiders own 2.90% of the company’s stock.

About Olin Corporation

Olin Corporation is a manufacturer and distributor of chemical products, and ammunition. The Company operates through three segments: Chlor Alkali Products and Vinyls, Epoxy and Winchester. The Chlor Alkali Products and Vinyls segment manufactures and sells chlorine and caustic soda, ethylene dichloride and vinyl chloride monomer, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products and potassium hydroxide.

Want to see what other hedge funds are holding OLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Olin Corporation (NYSE:OLN).

Institutional Ownership by Quarter for Olin Corporation (NYSE:OLN)

Receive News & Ratings for Olin Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.